Georgia's Silk Cloud deploys Nvidia Blackwell Ultra GPUs
Georgia's Silk Cloud deploys Nvidia Blackwell Ultra GPUs（摘要待生成）
Wall Street Lowers the Bar: Why Ford’s Q3 Earnings on Oct. 28 Could Trigger a Surprise October Breakout - Yahoo Finance
Wall Street Lowers the Bar: Why Ford’s Q3 Earnings on Oct. 28 Could Trigger a Surprise October Breakout - Yahoo Finance（摘要待生成）
American Express Stock Shocks Despite Positive Revenue and Earnings - Yahoo Finance
American Express Stock Shocks Despite Positive Revenue and Earnings - Yahoo Finance（摘要待生成）
Hexagon (OM:HEXA B) Stock Rally Ignores Q3 Earnings One Off Boost - Yahoo Finance
Hexagon (OM:HEXA B) Stock Rally Ignores Q3 Earnings One Off Boost - Yahoo Finance（摘要待生成）
VeriSign Q3 revenue beats estimates, EPS misses
Following results released Oct. 22, VeriSign reported Q3 revenue of $443 million, up 5.7% year over year, versus $440.58 million consensus; EPS was $2.35 versus $2.46 consensus. The page said VRSN opened at $300.32 on Oct. 23. It noted operating expenses rose to $147 million from $135 million year over year.
Billionaire Paul Tudor Jones warns AI and IPOs could hit stocks hard in 2027. Protect your nest egg now - Yahoo Finance
Billionaire Paul Tudor Jones warns AI and IPOs could hit stocks hard in 2027. Protect your nest egg now - Yahoo Finance（摘要待生成）
Sandisk's New Business Model Is Transforming the Business. Now Is the Time to Buy the Stock.
Sandisk's New Business Model Is Transforming the Business. Now Is the Time to Buy the Stock.（摘要待生成）
研究人员通过 DNS 数据库发现数千个公开的 Muse 聊天记录分享链接，Meta 已修复
研究人员通过 DNS 数据库发现数千个公开的 Muse 聊天记录分享链接，Meta 已修复（摘要待生成）
Bitcoin’s wealthy holders turning to loans and yield as investment habits mature: Xapo CEO
Bitcoin’s wealthy holders turning to loans and yield as investment habits mature: Xapo CEO（摘要待生成）
Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer
Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer（摘要待生成）
Wells Fargo, Cisco, Marvell among latest firms objecting to OKXICE's tokenized stock plan
Wells Fargo, Cisco, Marvell among latest firms objecting to OKXICE's tokenized stock plan（摘要待生成）
AIOK Stock Soars After $18M Dream Arrax Sale Spurs Speculation - StocksToTrade
AIOK Stock Soars After $18M Dream Arrax Sale Spurs Speculation - StocksToTrade（摘要待生成）
LKQ Stock Plunges As Weak Q3 Outlook Triggers Risk Repricing - StocksToTrade
LKQ Stock Plunges As Weak Q3 Outlook Triggers Risk Repricing - StocksToTrade（摘要待生成）
Chevron Is Taking a $3 Billion to $4 Billion Loss on Hess Midstream. Should You Buy the Stock Anyway?
Chevron Is Taking a $3 Billion to $4 Billion Loss on Hess Midstream. Should You Buy the Stock Anyway?（摘要待生成）
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
Genmab and Incyte have entered into a clinical trial collaboration to evaluate the combination of petosemtamab and INCB161734 in patients with KRAS G12D-mutated metastatic colorectal cancer.
Genmab and Incyte clinical-trial collaboration in KRAS G12D-mutated colorectal cancer
On October 24, 2026, Genmab and Incyte announced a Phase 1/2 collaboration to study petosemtamab plus Incyte’s investigational KRAS G12D inhibitor INCB161734 and standard chemotherapy as first-line treatment for KRAS G12D-mutated mCRC. Genmab will conduct the study; Incyte will co-fund it and provide clinical supply of INCB161734.